Literature DB >> 5413953

Supervision of epileptic patients taking phenytoin.

F B Gibberd, J F Dunne, A J Handley, B L Hazleman.   

Abstract

Serum phenytoin concentrations in outpatients and inpatients with epilepsy have been contrasted. Individual patients were receiving prescriptions ranging from 100 to 300 mg. of sodium phenytoin daily, but the two groups were comparable in respect of dosage, age, and sex distribution. Whereas the mean phenytoin concentration among 14 inpatients was 28 mug./ml. that among 15 outpatients was only 15.7 mug./ml. When the supervision of a further 12 outpatients was changed to include more frequent visits and regular provision of blood samples their mean serum concentration of phenytoin rose from 17.5 to 27.7 mug./ml.The results indicate that failure to follow dosage instructions is a factor of major importance among epileptic patients whose response to treatment is inadequate or erratic.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5413953      PMCID: PMC1699066          DOI: 10.1136/bmj.1.5689.147

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Determination of diphenylhydantoin and phenobarbital in small amounts of serum.

Authors:  O SVENSMARK; P KRISTENSEN
Journal:  J Lab Clin Med       Date:  1963-03

2.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.

Authors:  F BUCHTHAL; O SVENSMARK; P J SCHILLER
Journal:  Arch Neurol       Date:  1960-06

3.  Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients.

Authors:  H Kutt; F McDowell
Journal:  JAMA       Date:  1968-03-11       Impact factor: 56.272

4.  Some causes of ineffectiveness of diphenylhydantoin.

Authors:  H Kutt; J Haynes; F McDowell
Journal:  Arch Neurol       Date:  1966-05

5.  SERUM DIPHENYLHYDANTOIN (PHENYTOIN) IN AMBULANT PATIENTS WITH EPILEPSY.

Authors:  M LUND; R S JORGENSEN; V KUEHL
Journal:  Epilepsia       Date:  1964-03       Impact factor: 5.864

  5 in total
  19 in total

1.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

2.  Known epileptic patients brought to the accident and emergency department.

Authors:  N Hunt; V L Touquet
Journal:  J R Coll Gen Pract       Date:  1986-05

3.  Drug estimation in the treatment of epilepsy.

Authors:  A Richens
Journal:  Proc R Soc Med       Date:  1974-12

4.  Comparison of spectrophotometric and gas-liquid chromatographic measurements of serum diphenylhydantoin concentrations in epileptic out-patients.

Authors:  D Janz; D Schmidt
Journal:  J Neurol       Date:  1974-06-27       Impact factor: 4.849

5.  Pharmacokinetics of single and multiple doses of phenytoin in man.

Authors:  L Lund; G Alvan; A Berlin; B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Trial of maintenance therapy in schizophrenia.

Authors:  J P Leff; J K Wing
Journal:  Br Med J       Date:  1971-09-11

7.  [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

Authors:  D Schmidt; A Vogel
Journal:  Klin Wochenschr       Date:  1977-03-01

8.  The distribution of plasma phenytoin levels in epileptic patients.

Authors:  P T Lascelles; R S Kocen; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

9.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

10.  Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis.

Authors:  J K McQueen; D H Blackwood; P Harris; R M Kalbag; A L Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.